Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19
暂无分享,去创建一个
[1] D. MacFadden,et al. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression , 2021, Clinical Microbiology and Infection.
[2] S. Cosgrove,et al. Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study , 2020, Open forum infectious diseases.
[3] S. Jung,et al. Secondary infection among hospitalized COVID‐19 patients: A retrospective cohort study in a tertiary care setting , 2020, Respirology.
[4] M. Di Nisio,et al. Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 , 2020, European Journal of Internal Medicine.
[5] A. Rogers,et al. Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020 , 2020, Emerging infectious diseases.